Top

Published in:

01-12-2010 | Editorial

Some comments on the diagnosis of diabetes mellitus

Author: Takeshi Kuzuya

Published in: Diabetology International | Issue 2/2010

Excerpt

In 2010, the Japan Diabetes Society (JDS) presented a new report on the classification and diagnosis of diabetes mellitus in which the wide use of HbA1c was proposed for making the diagnosis [1]. This is the fourth report by the JDS on this subject, the first report being published in 1970 [2]. These four JDS reports [1, 2, 3, 4] retain the same principle regarding the concept of diabetes and the clinical use of the oral glucose tolerance test (OGTT) as a diagnostic tool, which differs somewhat from reports by the WHO and American Diabetes Association (ADA) [5, 6]. Here, I will comment on several points concerning the JDS reports. …

Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, Ito C, Inagaki N, Iwamoto Y, Kasuga M, Hanafusa T, Haneda M, Ueki K. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Diabetol Int. 2010;1:2–20.CrossRef

Kuzuya N, Abe M, Ueda H, Kuzuya K, Kuzuya T, Kosaka K, Goto Y, Shigeta Y, Baba S, Hirata Y, Horiuchi A, Yamada K, Wada M. Report of the committee on the diagnostic criteria of the oral glucose tolerance test for diabetes mellitus. J Jpn Diabetes Soc. 1970;13:1–7. (in Japanese).

Kosaka K, Akanuma Y, Goto Y, Hagura R, Hirata Y, Kawate R, Kuzuya T, Mimura G, Nakayama H, Sakamoto N, Shigeta Y. Report of the committee on the diagnosis of diabetes mellitus. J Jpn Diabetes Soc. 1982;25:859–66. (in Japanese).

Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, Nanjo K, Sasaki A, Seino Y, Ito C, Shima K, Nonaka K, Kadowaki T. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Jpn Diabetes Soc. 1999;42:385–404 (in Japanese) (English version; Diab Res Clin Pract. 2002;55:65–85).

The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183–97.

WHO Expert Committee on Diabetes Mellitus Second report. World Health Organization Tech Rep Ser. 1980;646:1–80.

Diabetes Mellitus. Report of a WHO committee. WHO Tech Rep Ser. 1965;310:1–44.

Kosaka K, Hagura R, Kuzuya T. Insulin responses in equivocal and definite diabetes, with special reference to subjects who had mild glucose intolerance but later developed definite diabetes. Diabetes. 1977;26:944–52.PubMed

National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039–57.

10.

Kosaka K, Mizuno Y, Kuzuya T. Reproducibility of the oral glucose tolerance test and the rice-meal test in mild diabetics. Diabetes. 1966;15:901–4.PubMed

11.

International Expert Committee. International expert committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32:1327–34.

12.

Shima K, Endo J, Oimomi M, Oshima I, Omori Y, Katayama Y, Kawai T, Kawamori R, Kanno T, Kiyose H, Nakashima K, Nagmine Y, Baba S, Hoshino T. Interlaboratory difference in HbA1c measurement in Japan—the interim report of the committee on an interlaboratory standardization of HbA1c determination. J Jpn Diabetes Soc. 1994;37:855–64 (in Japanese).

13.

Ito C, Maeda R, Ishida S, Sasaki H, Harada H. Correlations among fasting plasma glucose, two-hour plasma glucose levels in OGTT and HbA1c. Diab Res Clin Pract. 2000;50:225–30.CrossRef

Title: Some comments on the diagnosis of diabetes mellitus
Author: Takeshi Kuzuya
Publication date: 01-12-2010
Publisher: Springer Japan
Published in: Diabetology International / Issue 2/2010
Print ISSN: 2190-1678
Electronic ISSN: 2190-1686
DOI: https://doi.org/10.1007/s13340-011-0017-z

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2010

Comparative evaluation of angiotensin II receptor blockers on HOMA-R and adiponectin release in hypertensive patients with mild type 2 diabetes

Circulating monocyte chemoattractant protein-1 links to diabetic retinopathy in type 2 diabetic patients without renal dysfunction

Effects of hyperglycemia on oxidative stress and antioxidant potential in patients with type 2 diabetes

Investigation of clinical factors associated with development of chronic kidney disease and eGFR decline in Japanese patients with type 2 diabetes mellitus

Normal glucose tolerance with high HbA1c levels observed in two cases of Hb variants

Multifaceted intervention to promote the regular visiting of patients with diabetes to primary care physicians: rationale, design and conduct of a cluster-randomized controlled trial. The Japan Diabetes Outcome Intervention Trial-2 study protocol

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials